SCHEMBL30262139

SCHEMBL30262139

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.63

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 4/20 0.59
▸ NPY2R P49146 8/20 0.57
▸ NPY4R P50391 8/20 0.57
▸ NPY5R Q15761 8/20 0.57
▸ NPY1R P25929 6/20 0.57
▸ OPRD1 P41143 1/20 0.55
▸ GLP1R P43220 1/20 0.53
▸ GCGR P47871 1/20 0.53
▸ GIPR P48546 1/20 0.53
▸ TFPI P10646 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30262040 0.91 CALCR (0.59) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30432350 0.89 CALCR (0.60) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL31182524 0.88 CALCR (0.61) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL31000912 0.88 CALCR (0.54) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29811064 0.88 CALCR (0.66) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29461428 0.88 NTSR1 (0.59) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29416782 0.87 CALCR (0.62) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL31182956 0.87 NPY2R (0.65) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30495626 0.87 NPY2R (0.68) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30176420 0.87 NPY2R (0.68) CALCRNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback